Jefferies Group LLC Nektar Therapeutics Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Sep 21, 2023	BUY	$4.16 - $13.72 $391,040 - $1.29 Million	94,000 Added 95.92%	192,000 $1.03 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $391,040 - $1.29 Million	94,000 Added 95.92%	192,000 $1.04 Million
Q4 2021 Sep 21, 2023	BUY	$10.83 - $18.41 $1.06 Million - $1.8 Million	98,000 New	98,000 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $1.06 Million - $1.8 Million	98,000 New	98,000 $1.32 Million
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $3.72 Million - $7.98 Million	-220,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $6.82 Million - $7.99 Million	220,000 New	220,000 $7.83 Million

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.